Difficulty: Medium
Average Score: 81%
Practice
According to the currect WHO guidelines new (untreated) sputum smear positive cases of pulmonary tuberculosis are to be treated with the following regimen
Correct answer
C
Rationale
In the context of treating new (untreated) sputum smear positive cases of pulmonary tuberculosis according to WHO guidelines, option C is the correct regimen. This option includes Isoniazid and Rifampin for the full 6-month duration, which are the cornerstone drugs for treating tuberculosis. Additionally, Pyrazinamide and Ethambutol/Streptomycin are added during the initial 2 months to effectively kill the bacteria and prevent resistance.
Option A is incorrect because it lacks Pyrazinamide, which is crucial for the initial phase of treatment. Option B is incorrect as Thiacetazone is not recommended due to potential adverse effects. Option D is also incorrect because it lacks Ethambutol/Streptomycin, which are important for preventing resistance and improving treatment efficacy.
In an educational context, understanding the rationale behind each drug in the regimen is essential for nurses and healthcare professionals to provide safe and effective care to patients with tuberculosis. Knowing the correct drug combinations, durations, and potential side effects can help prevent treatment failure and the development of multidrug-resistant tuberculosis strains.
Option A is incorrect because it lacks Pyrazinamide, which is crucial for the initial phase of treatment. Option B is incorrect as Thiacetazone is not recommended due to potential adverse effects. Option D is also incorrect because it lacks Ethambutol/Streptomycin, which are important for preventing resistance and improving treatment efficacy.
In an educational context, understanding the rationale behind each drug in the regimen is essential for nurses and healthcare professionals to provide safe and effective care to patients with tuberculosis. Knowing the correct drug combinations, durations, and potential side effects can help prevent treatment failure and the development of multidrug-resistant tuberculosis strains.